Acer stock alert: halper sadeh llc is investigating whether the sale of acer therapeutics inc. is fair to shareholders

New york--(business wire)--halper sadeh llc, an investor rights law firm, is investigating whether the sale of acer therapeutics inc. (nasdaq: acer) to zevra therapeutics, inc. for 0.121 of a share of zevra's common stock for each share of acer's common stock is fair to acer shareholders. additionally, acer stockholders would receive non-transferable contingent value rights entitling them to receive up to $34 million in cash upon the achievement of certain commercial milestones for olpruva, and.
ACER Ratings Summary
ACER Quant Ranking